|
PRESS RELEASES AND OTHER NEWS
|
|
APRIL 22, 2009 |
Halo Completes $14.6 Million in Financing.
Halo Pharmaceutical, this week announced that it has completed $14.6 million in financing from The Provident Bank to expand its operations.
READ MORE  |
APRIL 20, 2009 |
Halo Welcomes Dr. George Bobotas as its Chief Scientific Officer.
As part of a Research and Development partnership between Halo Pharmaceutical and DeMelleBioPharma, LLC, Dr. George Bobotas joins Halo Pharmaceutical as Chief Scientific Officer.
READ MORE |
MARCH 3, 2009 |
Halo Launched in Canada.
Halo has announced today that it is establishing a Canadian subsidiary to be called Halo Pharmaceutical Marketing (Canada) Ltd.
READ MORE |
JANUARY 26, 2009 |
Allen Rosenston appointed VP Business Development.
Adding to its strong executive team, Halo announced the addition of Allen M. Rosenston, a thirty-five year pharmaceutical industry veteran, as Halo's new Vice President of Business Development.
READ MORE |
JANUARY 6, 2009 |
Halo Pharmaceutical, Inc. Acquires Whippany Manufacturing Facility from Abbott.
Halo completes its acquisition of the Whippany-NJ Manufacturing and Research facility from Abbott.
READ MORE |
|